GEO Q3 Net Income Plunges 80% to $16.4 Million on Debt Charges Despite 0.6% Revenue Increase

SEC Track
2024-11-13

Core Highlights: Net income decreased significantly by 80% to $16.4 million compared to the prior year period, primarily due to an $85.3 million loss on debt extinguishment related to refinancing activities. Gross margin remained relatively stable at 85.7%.
Revenue Breakdown: Revenue grew modestly by 0.6% to $1.82 billion: - U.S. Corrections & Detention revenue was flat as higher rates offset population changes. - Reentry Services revenue increased 4.8% driven by higher rates and populations. - Electronic Monitoring revenue grew 4.4% due to increased services provided. - International Services revenue declined 6.1% due to contract terminations and FX fluctuations. Management expects increased facility utilization from recent contract awards to drive future revenue growth.
Management Outlook: Management highlighted continued demand for secure services, reentry programs and electronic monitoring. They remain focused on prudent debt management and securing new contracts for growth. Management sees positive long-term outlook driven by expected increases in facility populations and demand for rehabilitation services under the GEO Continuum of Care platform.
Operating Data: Operating expenses increased 0.9% to $1.33 billion. Interest expense decreased 10.6% to $147.4 million due to refinancing. Cash flow from operations was $223.8 million. At 9/30/2024, cash was $118.4 million and long-term debt was $1.64 billion. Under the same loss conditions for Q3 2024, the current cash can support operations for approximately 4 quarters.
Operational Risks: Key risks include government policy changes impacting public-private partnerships, contract compliance issues, rising costs, ability to obtain new contracts, currency fluctuations, rising interest rates impacting debt costs.

Original Filing

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10